{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:40:02Z","timestamp":1768354802562,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.nucmedbio.2015.10.002","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T08:05:21Z","timestamp":1445760321000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of [ 18 F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Gopal","family":"Pathuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andria F.","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibhudutta","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Benjamin D.","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariprasad","family":"Gali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","article-title":"Molecular diagnostics for autosomal dominant polycystic kidney disease","volume":"6","author":"Harris","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0010","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0020","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ki.1996.387","article-title":"Role of obstruction in autosomal dominant polycystic kidney disease in rats","volume":"50","author":"Tanner","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0035","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0040","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","article-title":"Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats","volume":"60","author":"Cowley","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1983.51","article-title":"Rate of functional deterioration in polycystic kidney disease","volume":"23","author":"Franz","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0055","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcp.12136","article-title":"New treatments for autosomal dominant polycystic kidney disease","volume":"76","author":"Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0065","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0070","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2215\/CJN.00060108","article-title":"Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies","volume":"3","author":"Chapman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrneph.2009.214","article-title":"Imaging for the prognosis of autosomal dominant polycystic kidney disease","volume":"6","author":"Bae","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiology.211.3.r99jn19623","article-title":"Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging","volume":"211","author":"Bakker","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0085","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.08.026","article-title":"Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)","volume":"46","author":"O'Neill","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0090","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1046\/j.1523-1755.2000.00433.x","article-title":"Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography","volume":"58","author":"Sise","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0095","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.V1181505","article-title":"Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease","volume":"11","author":"King","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2215\/CJN.03750708","article-title":"MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement","volume":"4","author":"Bae","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0105","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.113.133447","article-title":"Radionuclides in nephrourology, part 1: radiopharmaceuticals, quality control, and quantitative indices","volume":"55","author":"Taylor","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.semnuclmed.2013.10.008","article-title":"Molecular imaging of urogenital diseases","volume":"44","author":"Cho","year":"2014","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0090-4295(98)00081-8","article-title":"Renal tubular dysfunction in patients with cystic disease of the kidneys","volume":"51","author":"Pabico","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2967\/jnumed.110.075895","article-title":"Synthesis and in vivo evaluation of p-18F-fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET","volume":"52","author":"Awasthi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0125","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/MNM.0b013e32834a6db6","article-title":"Renogram comparison of p-[18F]fluorohippurate with o-[125I]iodohippurate and [99mTc]MAG3 in normal rats","volume":"32","author":"Pathuri","year":"2011","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.nucmedbio.2012.07.002","article-title":"Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent","volume":"39","author":"Pathuri","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0135","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1681\/ASN.2005060601","article-title":"Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy\/+) rat","volume":"16","author":"Brown","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0140","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.2353\/ajpath.2010.100569","article-title":"Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats","volume":"177","author":"Neudecker","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1538\/expanim.61.477","article-title":"Animal models for human polycystic kidney disease","volume":"61","author":"Nagao","year":"2012","journal-title":"Exp Anim"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/030098588902600302","article-title":"Hereditary polycystic kidney disease associated with osteorenal syndrome in rats","volume":"26","author":"Kaspareit-Rittinghausen","year":"1989","journal-title":"Vet Pathol"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1994.253","article-title":"Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease","volume":"46","author":"Schafer","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.1993.79","article-title":"Autosomal-dominant polycystic kidney disease in the rat","volume":"43","author":"Cowley","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.nucmedbio.2015.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.00360110","article-title":"Early renal abnormalities in autosomal dominant polycystic kidney disease","volume":"5","author":"Meijer","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115001717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:23:33Z","timestamp":1718151813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805115001717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0969805115001717"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.10.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of [18F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}